Recurrent Ovarian Germ Cell Tumor Completed Phase 1 Trials for Denileukin diftitox (DB00004)

DBCOND0029793 (Recurrent Ovarian Germ Cell Tumor)Completed1 IdentifierTitlePurposeDrugs
NCT00228358Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu VaccineTreatment